Kontafarma China Holdings Limited

HK$0.03As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1312Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (26.62%)
Div yield —
ROE (47.17%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.11
PE TTM —
TSR TTM (6.90%)
Mkt cap HK$150.9M
ROIC (11.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0287
6.45%
(70.93%)
Hold 7|3|3|8|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
8.97%
19.98%
9.18%
5.83%
Revenue$M
6.985
7.049
7.279
7.648
7.10%
7.02%
4.70%
9.49%
Peers (US$19.25M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.674
0.402
0.269
EBIT/Intx
0.619
0.428
0.400
Own earn%
74.42
68.72
72.14
Sh yield%
41.91
58.19
57.13
Owners
Insiders/Inst%
4.84
45.45
Short interest%
5.00
SBC / revenue%
2.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
24–29
$1 testx
—
Incr. ROIC%
7